(Q68852468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Aminoglutethimide enzyme induction: pharmacological and endocrinological implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

241-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02897223

28 September 2019

exact match

0 references

cites work

16-Hydroxylation of Estrone-3-Sulfate and Estrone in the Guinea Pig in Vivo*

1 reference

12 December 2020

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics of aminoglutethimide.

1 reference

12 December 2020

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

1 reference

12 December 2020

Alterations in the urine excretion of estrogen metabolites in breast cancer women treated with aminoglutethimide

1 reference

12 December 2020

New endocrine drugs for treatment of advanced breast cancer

1 reference

12 December 2020

Assessment of antipyrine kinetics by measurement in saliva

1 reference

12 December 2020

In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway

1 reference

12 December 2020

Determination of aminoglutethimide and N-acetylaminoglutethimide in human plasma by reversed-phase liquid chromatography

1 reference

12 December 2020

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

1 reference

12 December 2020

Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide

1 reference

12 December 2020

Determination of warfarin in human plasma by high performance liquid chromatography and photodiode array detector

1 reference

12 December 2020

Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer

1 reference

12 December 2020

The effect of acetylator phenotype on the disposition of aminoglutethimide

1 reference

12 December 2020

A dose response evaluation of delta-1-testololactone in advanced breast cancer.

1 reference

12 December 2020

Separation of urinary metabolites of radiolabelled estrogens in man by HPLC.

1 reference

12 December 2020

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

1 reference

12 December 2020

Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings

1 reference

12 December 2020

Effects of drugs and environmental chemicals on steroid metabolism

1 reference

12 December 2020

Effects of aminoglutethimide on adrenal steroid secretion

1 reference

12 December 2020

The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer

1 reference

12 December 2020

A study of estrogen metabolic clearance rates and transfer factors

1 reference

12 December 2020

Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer

1 reference

12 December 2020

Plasma levels of estradiol, estrone, estrone sulfate and sex hormone binding globulin in patients receiving rifampicin

1 reference

12 December 2020

Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition

1 reference

12 December 2020

Micro-scale method for theophylline in body fluids by reversed-phase, high-pressure liquid chromatography

1 reference

12 December 2020

Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*

1 reference

12 December 2020

Serum Aminoglutethimide Levels: Studies of Serum Half-Life, Clearance, and Patient Compliance

1 reference

12 December 2020

Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients

1 reference

12 December 2020

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

1 reference

12 December 2020

Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer

1 reference

12 December 2020

Potency of the effect of D-stereoisomer of aminoglutethimide on adrenal and extraadrenal steroidogenesis

1 reference

12 December 2020

Aminoglutethimide and warfarin. A new important drug interaction

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02897223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369789%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference